Monitoring committee in clinical trials
dc.contributor.author | Lima B.B. | |
dc.contributor.author | de Andrade M.D.R. | |
dc.contributor.author | Rocha J.T. | |
dc.contributor.author | Calegari L.R.D.M. | |
dc.contributor.author | Neves V.V. | |
dc.date.accessioned | 2025-04-01T06:19:22Z | |
dc.date.available | 2025-04-01T06:19:22Z | |
dc.date.issued | 2025 | |
dc.description.abstract | © 2025 Elsevier Inc. All rights reserved.Monitoring committees serve as integral components in translational cardiology research. Their key responsibilities include safeguarding trial participants' well-being and rights and evaluating the effectiveness of the tested intervention. Through meticulous supervision of the trial's progression, these committees contribute significantly to the accuracy and dependability of the research outcomes. This chapter underscores the pivotal role of monitoring committees in transitioning laboratory discoveries into practical clinical applications in cardiology. By ensuring the safety and efficacy of new treatments, these committees play a crucial role in advancing patient care in cardiovascular disease. | |
dc.description.firstpage | 381 | |
dc.description.lastpage | 383 | |
dc.identifier.doi | 10.1016/B978-0-323-91790-2.00014-9 | |
dc.identifier.uri | https://dspace.mackenzie.br/handle/10899/40367 | |
dc.relation.ispartof | Translational Cardiology | |
dc.rights | Acesso Restrito | |
dc.subject.otherlanguage | Cardiology | |
dc.subject.otherlanguage | Efficacy | |
dc.subject.otherlanguage | Ethics | |
dc.subject.otherlanguage | Monitoring committees | |
dc.subject.otherlanguage | Safety | |
dc.subject.otherlanguage | Translational research | |
dc.title | Monitoring committee in clinical trials | |
dc.type | Capítulo de livro | |
local.scopus.citations | 0 | |
local.scopus.eid | 2-s2.0-85218385652 | |
local.scopus.updated | 2025-04-01 | |
local.scopus.url | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85218385652&origin=inward |